| Title : The effects of the concentration-dependent erythrocyte distribution of TAK-802, a potent acetylcholinesterase inhibitor, on rat pharmacokinetics - Kakehi_2016_Biopharm.Drug.Dispos_37_467 |
| Author(s) : Kakehi M , Tagawa Y , Goto A , Kondo T , Asahi S |
| Ref : Biopharmaceutics & Drug Disposition , 37 :467 , 2016 |
| Abstract : Kakehi_2016_Biopharm.Drug.Dispos_37_467 |
| ESTHER : Kakehi_2016_Biopharm.Drug.Dispos_37_467 |
| PubMedSearch : Kakehi_2016_Biopharm.Drug.Dispos_37_467 |
| PubMedID: 27554287 |
| Title : Main metabolic pathways of TAK-802, a novel drug candidate for voiding dysfunction, in humans: the involvement of carbonyl reduction by 11beta-hydroxysteroid dehydrogenase 1 - Nishihara_2014_Drug.Res.(Stuttg)_64_476 |
| Author(s) : Nishihara M , Takahashi J , Kondo T , Mouri K , Asahi S |
| Ref : Drug Res (Stuttg) , 64 :476 , 2014 |
| Abstract : Nishihara_2014_Drug.Res.(Stuttg)_64_476 |
| ESTHER : Nishihara_2014_Drug.Res.(Stuttg)_64_476 |
| PubMedSearch : Nishihara_2014_Drug.Res.(Stuttg)_64_476 |
| PubMedID: 24357138 |
| Title : Disposition of the new potent acetylcholinesterase inhibitor 8-[3-[1-[(3-fluorophenyl)methyl]-4-piperidiny]-1-oxopropyl]-1, 2, 5, 6-tetrahydro-4H-pyrrolo [3, 2, 1-ij] quinolin-4-one (TAK-802) in rats, dogs and monkeys - Kakehi_2013_Drug.Res.(Stuttg)_63_293 |
| Author(s) : Kakehi M , Tagawa Y , Kondo T , Asahi S |
| Ref : Drug Res (Stuttg) , 63 :293 , 2013 |
| Abstract : Kakehi_2013_Drug.Res.(Stuttg)_63_293 |
| ESTHER : Kakehi_2013_Drug.Res.(Stuttg)_63_293 |
| PubMedSearch : Kakehi_2013_Drug.Res.(Stuttg)_63_293 |
| PubMedID: 23585302 |